BDTX
Black Diamond Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.12
+0.95%Aug 5, 2026, 00:00 UTC
Black Diamond Therapeutics reported Q2 2026 financial results with a net loss of $9.9 million and cash and investments of $110.5 million as of June 30, 2026.